Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
45 hedge funds and large institutions have $3.34M invested in Applied Genetic Technologies Corporation in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
4% less funds holding
Funds holding: 47 → 45 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
61% less capital invested
Capital invested by funds: $8.49M → $3.34M (-$5.16M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
+$535K |
| 2 |
Renaissance Technologies
New York
|
+$363K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$185K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$78.9K |
| 5 |
CG
Colony Group
Boston,
Massachusetts
|
+$49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$625K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$220K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$120K |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$77K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$67K |
AGTC Hedge Fund Activity: Q3 2022 in Review
45 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2022, worth a combined $3.34M — down 61% from $8.49M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AGTC and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 11 added.
The largest buyer was Kingdon Capital Management, opening a new position worth an estimated $535K. The largest seller was Sabby Management, exiting entirely with an estimated $625K sold.
- 45 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2022, down from 47 in Q2 2022.
- Funds reported $3.34M of Applied Genetic Technologies Corporation stock for Q3 2022, down 61% quarter-over-quarter.
- 8 funds opened new Applied Genetic Technologies Corporation positions in Q3 2022 and 10 closed out, a net change of -2 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2022 was Kingdon Capital Management, an estimated $535K added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2022 was Sabby Management, an estimated $625K sold.
Based on aggregated 13F filings for Q3 2022.